These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 11716473)

  • 21. Cellular prion protein co-localizes with nAChR beta4 subunit in brain and gastrointestinal tract.
    Petrakis S; Irinopoulou T; Panagiotidis CH; Engelstein R; Lindstrom J; Orr-Urtreger A; Gabizon R; Grigoriadis N; Sklaviadis T
    Eur J Neurosci; 2008 Feb; 27(3):612-20. PubMed ID: 18279314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prion protein glycosylation.
    Lawson VA; Collins SJ; Masters CL; Hill AF
    J Neurochem; 2005 May; 93(4):793-801. PubMed ID: 15857383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spongiform encephalopathies. Tracking turncoat prion proteins.
    Masters CL; Beyreuther K
    Nature; 1997 Jul; 388(6639):228-9. PubMed ID: 9230425
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapeutic approaches targeting the prion receptor LRP/LR.
    Zuber C; Ludewigs H; Weiss S
    Vet Microbiol; 2007 Aug; 123(4):387-93. PubMed ID: 17498894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
    Sasaki K; Minaki H; Iwaki T
    J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microglia and prion disease: a review.
    Brown DR; Kretzschmar HA
    Histol Histopathol; 1997 Jul; 12(3):883-92. PubMed ID: 9225170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infection.
    Lewis V; Hill AF; Haigh CL; Klug GM; Masters CL; Lawson VA; Collins SJ
    J Neuropathol Exp Neurol; 2009 Oct; 68(10):1125-35. PubMed ID: 19918124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneous PrPC metabolism in skeletal muscle cells.
    Massimino ML; Ferrari J; Sorgato MC; Bertoli A
    FEBS Lett; 2006 Feb; 580(3):878-84. PubMed ID: 16430889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmissible spongiform encephalopathies and prion protein interconversions.
    Caughey B; Chesebro B
    Adv Virus Res; 2001; 56():277-311. PubMed ID: 11450303
    [No Abstract]   [Full Text] [Related]  

  • 30. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
    Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single chain Fv antibodies directed against the 37 kDa/67 kDa laminin receptor as therapeutic tools in prion diseases.
    Zuber C; Knackmuss S; Rey C; Reusch U; Röttgen P; Fröhlich T; Arnold GJ; Pace C; Mitteregger G; Kretzschmar HA; Little M; Weiss S
    Mol Immunol; 2008 Jan; 45(1):144-51. PubMed ID: 17576014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of proteins with high affinity for refolded and native PrPC.
    Petrakis S; Sklaviadis T
    Proteomics; 2006 Dec; 6(24):6476-84. PubMed ID: 17111435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific inhibition of pathological prion protein accumulation by small interfering RNAs.
    Daude N; Marella M; Chabry J
    J Cell Sci; 2003 Jul; 116(Pt 13):2775-9. PubMed ID: 12759373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scrg1 is induced in TSE and brain injuries, and associated with autophagy.
    Dron M; Bailly Y; Beringue V; Haeberlé AM; Griffond B; Risold PY; Tovey MG; Laude H; Dandoy-Dron F
    Eur J Neurosci; 2005 Jul; 22(1):133-46. PubMed ID: 16029203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mouse-adapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture.
    Lawson VA; Vella LJ; Stewart JD; Sharples RA; Klemm H; Machalek DM; Masters CL; Cappai R; Collins SJ; Hill AF
    Int J Biochem Cell Biol; 2008; 40(12):2793-801. PubMed ID: 18590830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prion's elusive reason for being.
    Aguzzi A; Baumann F; Bremer J
    Annu Rev Neurosci; 2008; 31():439-77. PubMed ID: 18558863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance of cell lines to prion toxicity aided by phospho-ERK expression.
    Uppington KM; Brown DR
    J Neurochem; 2008 May; 105(3):842-52. PubMed ID: 18088369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
    Surewicz WK; Jones EM; Apetri AC
    Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oligodendrocytes are susceptible to apoptotic cell death induced by prion protein-derived peptides.
    Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Olivier JL; Pillot T
    Glia; 2004 Jul; 47(1):1-8. PubMed ID: 15139007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.